Neuroglia

Neuroglia (ISSN 2571-6980) is an international, peer-reviewed, open access journal dedicated to the rapidly evolving field of glial cell biology. Published by MDPI, the journal provides a comprehensive platform for the dissemination of research on all aspects of neuroglial function and dysfunction. Its scope encompasses the molecular, cellular, and systemic roles of astrocytes, oligodendrocytes, microglia, Schwann cells, and other glial populations in both the central and peripheral nervous systems. The journal covers a wide array of topics, including glial development, metabolism, signaling, neuroinflammation, myelination, synaptic modulation, and the contribution of glial cells to neurological disorders such as multiple sclerosis, Alzheimer’s disease, stroke, and gliomas. Neuroglia publishes a variety of article types, including original research articles, comprehensive reviews, short communications, and technical notes, ensuring broad coverage from fundamental discoveries to translational applications. The target audience includes neuroscientists, cell biologists, neurologists, and clinical researchers seeking to deepen their understanding of glial physiology and pathology. A notable feature of the journal is its open access model, which ensures that all published content is freely accessible to the global scientific community, promoting wider visibility and impact. With a 2026 Impact Factor of 2.2000, Neuroglia holds a solid position within its niche, reflecting its growing recognition as a specialized outlet for glial research. This impact factor places the journal in a competitive tier for dedicated neuroscience subfields, making it a valuable resource for researchers aiming to contribute to and stay current with advances in glial science.